Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation (Q44796931)

6 December 2017

title

Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation (English)

1 reference

6 December 2017

I V Smirnova

1

1 reference

6 December 2017

M Kajstura

series ordinal

2

1 reference

6 December 2017

T Sawamura

series ordinal

3

1 reference

6 December 2017

M S Goligorsky

series ordinal

4

1 reference

6 December 2017

publication date

11 March 2004

1 reference

American Journal of Physiology Heart and Circulatory Physiology

6 December 2017

published in

1 reference

6 December 2017

volume

287

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

H782-90

1 reference

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Does ADMA cause endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Lectin-like oxidized LDL receptor-1 (LOX-1) supports adhesion of mononuclear leukocytes and a monocyte-like cell line THP-1 cells under static and flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Nitric oxide prevents oxidised LDL-induced p53 accumulation, cytochrome c translocation, and apoptosis in macrophages via guanylate cyclase stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Metabolism of oxidized LDL by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

The L-arginine-nitric oxide pathway in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Constitutive nitric oxide production in bovine aortic and brain microvascular endothelial cells: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Endothelial cells play an important role in the antiaggregatory effect of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Macrophage foam cell formation with native low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

The macrophage foam cell as a target for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Uptake of oxidized LDL by macrophages differs from that of acetyl LDL and leads to expansion of an acidic endolysosomal compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Effects of guanidino and uremic compounds on nitric oxide pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Inhibition of LOX-1 by statins may relate to upregulation of eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

An endothelial receptor for oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Macrophage cholesterol transport: a critical player in foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Importance of asymmetrical dimethylarginine in cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Scavenger receptors and modified lipoproteins: fatal attractions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

Role of oxidized LDL in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00822.2003

10.1152/AJPHEART.00822.2003

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference